Forensic application of three interstitial pneumonia markers: search for new pneumonia markers in dead bodies
International Journal of Legal Medicine · 2024
DOI: 10.1007/s00414-024-03187-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Legal Medicine, 2024. Verfasst von Keisuke Okaba und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, School of Medicine, International University of Health and Welfare, Narita, Japan. k.okaba@iuhw.ac.jp. Hauptthemen laut MEDLINE: Mucin-1, Lung Diseases, Interstitial, Pulmonary Surfactant-Associated Protein D, Biomarkers. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
In forensic cases, detailed identification of pneumonia is important. Our objective was to statistically determine the applicability of three interstitial lung disease (ILD) markers for forensic diagnosis using serum collected from dead bodies with various postmortem intervals (PMIs). We retrospectively analyzed the levels of postmortem serum Krebs von den Lungen-6 (KL-6) and pulmonary surfactant-associated proteins A and D (SP-A and SP-D) using 221 samples obtained during forensic autopsy at our facility from 2019 to 2023. We evaluated the diagnostic efficacy of ILD markers for various pneumonias against the pathological diagnosis, and examined the assessment of the severity of ILD. When comparing the ILD group with bacterial pneumonia (BP) versus the control group, there was a significant increase in KL-6 in the ILD group. When comparing the severe ILD (SILD) group with the mild ILD (MILD) group, there was a significant increase in KL-6 and SP-D in the SILD group. The optimal cutoff values for differentiating SILD were 607.0 U/mL for KL-6, 55.5 ng/mL for SP-A, and 160.0 ng/mL for SP-D, and the sensitivity/specificity (%) of KL-6, SP-A, and SP-D for SILD were 84.1/95.2, 55.6/85.7, and 66.7/74.6, respectively. This is the first study to examine KL-6 in postmortem serum in forensic medicine. By analyzing dead bodies with various PMIs, our results confirmed statistically that postmortem serum KL-6 specifically detects ILD, postmortem serum SP-A has high sensitivity to lung injury, and postmortem serum SP-D is potentially useful in assessing the severity of ILD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Forensic Medicine, School of Medicine, International University of Health and Welfare, Narita, Japan. k.okaba@iuhw.ac.jp.
- Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. k.okaba@iuhw.ac.jp.
- Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Forensic Medicine, School of Medicine, International University of Health and Welfare, Narita, Japan.
- Department of Forensic Medicine, Research Unit of Internal Medicine, Medical Research Center, University of Oulu, Oulu, Finland.
- Department of Pathology, School of Medicine, International University of Health and Welfare, Narita, Japan.
Zitieren
APA
Okaba, K., Inokuchi, G., Horioka, K., Iwase, H., Inoue, H., Motomura, A., Ishii, N., Moue, C., Shiomi, T., & Yajima, D. (2024). Forensic application of three interstitial pneumonia markers: search for new pneumonia markers in dead bodies. International Journal of Legal Medicine. https://doi.org/10.1007/s00414-024-03187-2
Vancouver
Okaba K, Inokuchi G, Horioka K, Iwase H, Inoue H, Motomura A, et al. Forensic application of three interstitial pneumonia markers: search for new pneumonia markers in dead bodies. International Journal of Legal Medicine. 2024. doi:10.1007/s00414-024-03187-2
BibTeX
@article{Okaba2024,
author = {Okaba, Keisuke and Inokuchi, Go and Horioka, Kie and Iwase, Hirotaro and Inoue, Hiroyuki and Motomura, Ayumi and Ishii, Namiko and Moue, Chihiro and Shiomi, Takayuki and Yajima, Daisuke},
title = {Forensic application of three interstitial pneumonia markers: search for new pneumonia markers in dead bodies},
journal = {International Journal of Legal Medicine},
year = {2024},
doi = {10.1007/s00414-024-03187-2}
}
EUVIMED